Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer
Clinical trial NCT06015035 · COMPLETED
Trial details
- NCT number
- NCT06015035
- Sponsor
- Tang-Du Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2022-04-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.